Sfoglia per Autore
Anti-endothelin drugs in solid tumors
2010-01-01 Russo, A; Bronte, G; Rizzo, S; Fanale, D; Di Gaudio, F; Gebbia, N; Bazan, V.
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma
2010-01-01 Bronte, G; Rizzo, S; La Paglia, L; Adamo, V; Siragusa, S; Ficorella, C; Santini, D; Bazan, V; Colucci, G; Gebbia, N; Russo, A
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
2010-01-01 Rizzo,S; Bronte, G; Fanale, D; Corsini, LR; Silvestris, N; Santini, D; Gulotta, G; Bazan, V; Gebbia, N; Fulfaro, F; Russo A
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway
2010-01-01 Russo, A.; Rizzo, S.; Bronte, G.; Silvestris, N.; Colucci, G.; Gebbia, N.; Bazan, V.; Fulfaro, F.
HER2-positive male breast cancer: An update
2010-01-01 Ottini, L.; Capalbo, C.; Rizzolo, P.; Silvestri, V.; Bronte, G.; Rizzo, S.; Russo, A.
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib.
2010-01-01 Vincenzi, B; Santini, D; Russo, A; Addeo, R; Giuliani, F; Montella, L; Rizzo, S; Venditti, O; Frezza, AM; Caraglia, M; Colucci, G; Del Prete, S; Tonini, G
Bortezomib: a new pro-apoptotic agent in cancer treatment.
2010-01-01 Russo, A; Bronte, G; Fulfaro, F; Cicero, G; Adamo, V; Gebbia, N; Rizzo, S
Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer
2010-01-01 Santini, D; Vincenzi, B; Fratto, M; Perrone, G; Lai, R; Catalano, V; Cass, C; Ruffini, P; Spoto, C; Muretto, P; Rizzo, S; Muda, A; Mackey, J; Russo, A; Tonini, G; Graziano, F
EGFR genomic alterations in cancer: prognostic and predictive values
2011-01-01 Bronte, G; Terrasi, M; Rizzo, S; Sivestris, N; Ficorella, C; Cajozzo, M; Di Gaudio, F; Gulotta, G; Siragusa, S; Gebbia, N; Russo, A
Biomarkers and efficacy: Are we nearly there yet?
2011-01-01 Russo, A.; Rizzo, S
Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules
2011-01-01 Caraglia, M.; Santini, D.; Bronte, G.; Rizzo, S.; Sortino, G.; Rini, G.; Di Fede, G.; Russo, A.
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors
2011-01-01 Di Fede, G; Bronte, G; Rizzo, S; Rolfo Cervetto, C; Cocorullo, G; Gulotta, G; Bazan, V; Russo, A
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)
2011-01-01 Santini, D; Schiavon, G; Vincenzi, B; Cass, C; Vasile, E; Manazza, A; Catalano, V; Baldi, G; Lai, R; Rizzo, S; Giacobino, A; Chiusa, L; Caraglia, M; Russo, A; Mackey, J; Falcone, A; Tonini, G
"ONCOGENE ADDICTED SOLID TUMORS: BIOMARKERS PROGNOSTIC AND PREDICTIVE OF RESISTANCE OR SENSITIVITY TO MOLECULAR TARGETED THERAPIES IN CRC
2011-04-01 Rizzo, .
Gene signatures in CRC and liver metastasis
2012-01-01 Fanale, Daniele*; Corsini, Lidia; Rizzo, Sergio; Russo, Antonio
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness?
2012-01-01 Caruso, S; Bazan, V; Rolfo, C; Insalaco, L; Fanale, D; Bronte, G; Corsini, L; Rizzo, S; Cicero, G; Russo, A
PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy.
2012-01-01 Vincenzi, B, Santini, D; Schiavon, G; Frezza AM; Silletta, M; Crucitti, P; Casali, P; Dei Tos, AP; Rossi, S, Rizzo, S; Badalamenti, G; Tomasino, RM; Russo, A; Butrynski, JE; Tonini, G.
Breast cancer genome-wide association studies: there is strength in numbers
2012-01-01 Fanale, D; Amodeo, V; Corsini, LR; Rizzo, S; Bazan, V; Russo, A
PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients
2012-01-01 Vincenzi B, Santini D, Perrone G, Graziano F, Loupakis, F; Schiavon, G; Frezza, AM; Ruzzo, AM; Rizzo, S; Crucitti, P; Galluzzo, S; Zoccoli, A; Rabitti, C; Muda, AO; Russo, A; Falcone, A; Tonini, G
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population
2013-01-01 Adamo, V; Ricciardi, G; Adamo, B; Ferraro, G; Franchina, T; Rossello, R; Zanghi, M; Cicero, G; Rizzo, S; Caristi, N; Russo, A
| Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
|---|---|---|---|---|---|
| 1-gen-2010 | Anti-endothelin drugs in solid tumors | RUSSO, AntonioBRONTE, GiuseppeRIZZO, SergioFANALE, DanieleDI GAUDIO, FrancescaGEBBIA, Nicolo'BAZAN, Viviana | 01 - Contributo in rivista::1.01 Articolo in rivista | Russo, A; Bronte, G; Rizzo, S; Fanale, D; Di Gaudio, F; Gebbia, N; Bazan, V. | |
| 1-gen-2010 | Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma | BRONTE, GiuseppeRIZZO, SergioLA PAGLIA, LauraSIRAGUSA, SergioBAZAN, VivianaGEBBIA, Nicolo'RUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Bronte, G; Rizzo, S; La Paglia, L; Adamo, V; Siragusa, S; Ficorella, C; Santini, D; Bazan, V; Colucci, G; Gebbia, N; Russo, A | |
| 1-gen-2010 | Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? | RIZZO, SergioBRONTE, GiuseppeFANALE, DanieleCORSINI, Lidia RitaGULOTTA, GaspareBAZAN, VivianaGEBBIA, Nicolo'FULFARO, FabioRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Rizzo,S; Bronte, G; Fanale, D; Corsini, LR; Silvestris, N; Santini, D; Gulotta, G; Bazan, V; Gebbia, N; Fulfaro, F; Russo A | |
| 1-gen-2010 | The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway | RUSSO, AntonioRIZZO, SergioBRONTE, GiuseppeBAZAN, VivianaFULFARO, Fabio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Russo, A.; Rizzo, S.; Bronte, G.; Silvestris, N.; Colucci, G.; Gebbia, N.; Bazan, V.; Fulfaro, F. | |
| 1-gen-2010 | HER2-positive male breast cancer: An update | BRONTE, GiuseppeRIZZO, SergioRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Ottini, L.; Capalbo, C.; Rizzolo, P.; Silvestri, V.; Bronte, G.; Rizzo, S.; Russo, A. | |
| 1-gen-2010 | Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib. | SANTINI, DanieleRUSSO, AntonioRIZZO, Sergio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Vincenzi, B; Santini, D; Russo, A; Addeo, R; Giuliani, F; Montella, L; Rizzo, S; Venditti, O; Frezza, AM; Caraglia, M; Colucci, G; Del Prete, S; Tonini, G | |
| 1-gen-2010 | Bortezomib: a new pro-apoptotic agent in cancer treatment. | RUSSO, AntonioBRONTE, GiuseppeFULFARO, FabioCICERO, GiuseppeGEBBIA, Nicolo'RIZZO, Sergio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Russo, A; Bronte, G; Fulfaro, F; Cicero, G; Adamo, V; Gebbia, N; Rizzo, S | |
| 1-gen-2010 | Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer | RIZZO, SergioRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Santini, D; Vincenzi, B; Fratto, M; Perrone, G; Lai, R; Catalano, V; Cass, C; Ruffini, P; Spoto, C; Muretto, P; Rizzo, S; Muda, A; Mackey, J; Russo, A; Tonini, G; Graziano, F | |
| 1-gen-2011 | EGFR genomic alterations in cancer: prognostic and predictive values | BRONTE, GiuseppeTERRASI, MariannaRIZZO, SergioCAJOZZO, MassimoDI GAUDIO, FrancescaGULOTTA, GaspareSIRAGUSA, SergioGEBBIA, Nicolo'RUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Bronte, G; Terrasi, M; Rizzo, S; Sivestris, N; Ficorella, C; Cajozzo, M; Di Gaudio, F; Gulotta, G; Siragusa, S; Gebbia, N; Russo, A | |
| 1-gen-2011 | Biomarkers and efficacy: Are we nearly there yet? | RUSSO, AntonioRIZZO, Sergio | 01 - Contributo in rivista::1.01 Articolo in rivista | Russo, A.; Rizzo, S | |
| 1-gen-2011 | Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules | SANTINI, DanieleBRONTE, GiuseppeRIZZO, SergioSORTINO, GiovanniRINI, Giovam BattistaDI FEDE, GaetanaRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Caraglia, M.; Santini, D.; Bronte, G.; Rizzo, S.; Sortino, G.; Rini, G.; Di Fede, G.; Russo, A. | |
| 1-gen-2011 | Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors | DI FEDE, GaetanaBRONTE, GiuseppeRIZZO, SergioCOCORULLO, GianfrancoGULOTTA, GaspareBAZAN, VivianaRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Di Fede, G; Bronte, G; Rizzo, S; Rolfo Cervetto, C; Cocorullo, G; Gulotta, G; Bazan, V; Russo, A | |
| 1-gen-2011 | Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC) | CATALANO, VeronicaLai, RobertoRIZZO, SergioRUSSO, AntonioFALCONE, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Santini, D; Schiavon, G; Vincenzi, B; Cass, C; Vasile, E; Manazza, A; Catalano, V; Baldi, G; Lai, R; Rizzo, S; Giacobino, A; Chiusa, L; Caraglia, M; Russo, A; Mackey, J; Falcone, A; Tonini, G | |
| 1-apr-2011 | "ONCOGENE ADDICTED SOLID TUMORS: BIOMARKERS PROGNOSTIC AND PREDICTIVE OF RESISTANCE OR SENSITIVITY TO MOLECULAR TARGETED THERAPIES IN CRC | RIZZO, Sergio | 04 - Tesi di dottorato::4.1 Tesi di dottorato pre 2013 | Rizzo, . | |
| 1-gen-2012 | Gene signatures in CRC and liver metastasis | Fanale, DanieleCorsini, LidiaRizzo, SergioRusso, Antonio | 02 - Contributo in volume::2.01 Capitolo o Saggio | Fanale, Daniele*; Corsini, Lidia; Rizzo, Sergio; Russo, Antonio | |
| 1-gen-2012 | MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? | CARUSO, StefanoBAZAN, VivianaINSALACO, LaviniaFANALE, DanieleBRONTE, GiuseppeCORSINI, Lidia RitaRIZZO, SergioCICERO, GiuseppeRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Caruso, S; Bazan, V; Rolfo, C; Insalaco, L; Fanale, D; Bronte, G; Corsini, L; Rizzo, S; Cicero, G; Russo, A | |
| 1-gen-2012 | PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy. | RIZZO, SergioBADALAMENTI, GiuseppeRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Vincenzi, B, Santini, D; Schiavon, G; Frezza AM; Silletta, M; Crucitti, P; Casali, P; Dei Tos, AP; Rossi, S, Rizzo, S; Badalamenti, G; Tomasino, RM; Russo, A; Butrynski, JE; Tonini, G. | |
| 1-gen-2012 | Breast cancer genome-wide association studies: there is strength in numbers | FANALE, DanieleAMODEO, ValeriaCORSINI, Lidia RitaRIZZO, SergioBAZAN, VivianaRUSSO, Antonio | 01 - Contributo in rivista::1.01 Articolo in rivista | Fanale, D; Amodeo, V; Corsini, LR; Rizzo, S; Bazan, V; Russo, A | |
| 1-gen-2012 | PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients | RIZZO, SergioRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Vincenzi B, Santini D, Perrone G, Graziano F, Loupakis, F; Schiavon, G; Frezza, AM; Ruzzo, AM; Rizzo, S; Crucitti, P; Galluzzo, S; Zoccoli, A; Rabitti, C; Muda, AO; Russo, A; Falcone, A; Tonini, G | |
| 1-gen-2013 | The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population | CICERO, GiuseppeRIZZO, SergioRUSSO, Antonio + | 01 - Contributo in rivista::1.01 Articolo in rivista | Adamo, V; Ricciardi, G; Adamo, B; Ferraro, G; Franchina, T; Rossello, R; Zanghi, M; Cicero, G; Rizzo, S; Caristi, N; Russo, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile